| For: | Li CB, Ning YT, Shen NY, Wang B, Xiao H, Luo G. Systemic treatment of liver cancer: Current status and future perspectives. World J Hepatol 2025; 17(7): 107520 [PMID: 40747233 DOI: 10.4254/wjh.v17.i7.107520] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i7/107520.htm |
| Number | Citing Articles |
| 1 |
Jintao Zheng, Guoqiang Cao, Jialing Zhao, Longjie Yu, Xiujin Ye, Junru Chen, Haiyang Xie, Jianhui Li, Changku Jia. Prognostic value of PRAME gene promoter methylation and expression in hepatocellular carcinoma. Clinical Epigenetics 2026; 18(1) doi: 10.1186/s13148-026-02152-7
|
| 2 |
Thi Tuyet Mai Nguyen, Cam Phuong Pham, Minh Phuong Vu. Neutrophil‑to‑lymphocyte ratio as a predictive marker for portal vein thrombosis in hepatocellular carcinoma. World Academy of Sciences Journal 2026; 8(3): 1 doi: 10.3892/wasj.2026.459
|
| 3 |
Chenlu Qian, Yan Wu, Chuan Yin, Jie Gao. Progress in hepatoprotective strategies during TACE treatment. Advanced Interventional Materials 2026; 1(1): 100012 doi: 10.1016/j.advim.2026.100012
|
| 4 |
Tanvi Desai, Ekta Rawat, Nitin G. Haswani, Shadma Wahab, Saad Ali Alshehri, Devesh U. Kapoor. Alginate-driven nanotherapeutics in liver cancer: design, applications, and future perspectives. International Journal of Pharmaceutics 2026; 696: 126844 doi: 10.1016/j.ijpharm.2026.126844
|